Home NDC 67112-402-30 TRICARE PRENATAL DHA ONE RX
Product NDC 67112-402
Requested package NDC 67112-402-30
11-digit product format 671120402
Labeler code 67112
Product ID 67112-402_4952d7c5-0c2e-4cf0-8bcf-a1cab52b9bfe
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name FISH OIL, DHA, EPA, VITAMINS B-1, B-2, B-3, B-6, B-12, C, D3, E, BIOTIN, IRON, ZINC, COPPER, IODINE, DOCUSATE SODIUM
Dosage form CAPSULE, GELATIN COATED
Route ORAL
Labeler Medecor Pharma, LLC
Marketing category UNAPPROVED DRUG OTHER
Marketing start 2019-03-15
Marketing end 0000-00-00
Substance FISH OIL; DOCONEXENT; ICOSAPENT; THIAMINE MONONITRATE; RIBOFLAVIN; INOSITOL NIACINATE; PYRIDOXINE HYDROCHLORIDE; CYANOCOBALAMIN; FOLIC ACID; ASCORBIC ACID; CHOLECALCIFEROL; .ALPHA.-TOCOPHEROL, D-; BIOTIN; FERROUS FUMARATE; ZINC SULFATE MONOHYDRATE; CUPRIC SULFATE ANHYDROUS; POTASSIUM IODIDE; DOCUSATE SODIUM
Active strength 500 mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; [iU]/1; [iU]/1; ug/1; mg/1; mg/1; mg/1; ug/1; ug/1
Pharmacologic classes Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Copper Absorption Inhibitor [EPC],Decreased Copper Ion Absorption [PE],Vitamin B 12 [CS],Vitamin B12 [EPC],Vitamin C [EPC],Ascorbic Acid [CS],Vitamin D [CS],Vitamin D [EPC]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 67112-402-30 67112040230 30 CAPSULE, GELATIN COATED in 1 BOTTLE (67112-402-30) 2019-03-15 0000-00-00 No No Current